Compare Mesoblast Limited (MESO) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Upwork Inc — how do they compare? Mesoblast Limited trades at $16.36 (market cap $2.17B), while Upwork Inc trades at $9.07 (market cap $1.15B). The key difference: Mesoblast Limited is the larger of the two by market cap, and Mesoblast Limited is trading nearer its 52-week high, Upwork Inc nearer its low. Which is the better fit depends on your goals.
| MESO | UPWK | |
|---|---|---|
Market Cap | $2.17B | $1.15B |
Sector | Technology | Industrials |
52-Week High | $20.96 | $22.11 |
52-Week Low | $12.88 | $7.84 |
Enterprise Value | $2.17B | $952.17M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.63, down 3.98% on the day, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth with Ryoncil generating $115 million in annual revenue, though it remains unprofitable with a net loss of $102 million. Recent developments include positive Phase 3 trial progress and FDA BLA filings for new treatments.
Investment outlook balances promising pipeline progress against significant financial losses. The stock offers growth potential through commercial expansion but carries substantial risk from continued cash burn and regulatory hurdles. Analyst consensus leans bullish with 45% buy ratings, reflecting optimism about the company's transition to commercial-stage operations.
UPWK trades at $9.33, up 2.98% today, with a neutral technical signal and mixed earnings history including recent EPS misses. Revenue grew to $787.78M in 2025 with strong profitability margins (net margin 13.81%), but cash flow turned negative. Analyst consensus is a Buy with a $10.67 target, though legal investigations and competitive pressures pose headwinds.
The stock offers value with low P/E (11.19) and EV/EBITDA (5.96), but risks include ongoing fraud probes and gig economy volatility. Upside depends on execution amid AI integration initiatives, while downside is cushioned by solid balance sheet liquidity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
